Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianni Malossini

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Cancer|October 6, 2010
Bladder cancer and BCG response prediction: what we must know?Tommaso Cai, Gianni Malossini
Cancer|May 9, 2012
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuriaTommaso Cai, Gianni Malossini, Riccardo Bartoletti
European Urology|March 15, 2011
Re: Samuel R. Denmeade, Blair Egerdie, Gary Steinhoff, et al. Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2011;59:747-54Tommaso Cai, Dalla Palma Paolo, Gianni Malossini
Urology|April 24, 2013
Reply: To PMID 23608665Lorenzo G Luciani, Gianni Malossini, Francesco Porpiglia
European Urology|March 16, 2010
Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 2010;57:766-73Tommaso Cai, Lorenzo Giuseppe Luciani, Gianni Malossini
European Urology|June 28, 2020
Re: Jan-Niclas Mumm, Andreas Osterman, Michael Ruzicka, et al. Urinary Frequency as a Possible Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.05.013: Severe Involvement of the Urinary Tract During COVID-19 InfectionLorenzo G Luciani, Fabrizio Gallo, Gianni Malossini
The Journal of Urology|November 25, 2010
Re: Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy: C. Von Bodman, G. Godoy, D. C. Chade, A. Cronin, L. J. Tafe, S. W. Fine, V. Laudone, P. T. Scardino and J. A. Eastham J Urol 2010; 184: 143-148Tommaso Cai, Gabriella Nesi, Gianni Malossini, et al.
The Journal of Antimicrobial Chemotherapy|December 28, 2010
Comment on: A potential role for daptomycin in enterococcal infections: what is the evidence?Tommaso Cai, Sandra Mazzoli, Gianni Malossini, et al.
The Journal of Urology|February 19, 2021
Delaying Cancer Cases in Urology during COVID-19: Review of the Literature. Letter.<i>J Urol</i> 2020; <b>204:</b> 926Tommaso Cai, Orazio Caffo, Gianni Malossini, et al.
Oncology Letters|April 20, 2013
Pelvic and muscular metastasis of a renal cell carcinoma: A case reportCarolina D'Elia, Tommaso Cai, Lorenzo Luciani, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Cancer|October 6, 2010
Bladder cancer and BCG response prediction: what we must know?Tommaso Cai, Gianni Malossini
Cancer|May 9, 2012
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuriaTommaso Cai, Gianni Malossini, Riccardo Bartoletti
European Urology|March 15, 2011
Re: Samuel R. Denmeade, Blair Egerdie, Gary Steinhoff, et al. Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2011;59:747-54Tommaso Cai, Dalla Palma Paolo, Gianni Malossini
Urology|April 24, 2013
Reply: To PMID 23608665Lorenzo G Luciani, Gianni Malossini, Francesco Porpiglia
European Urology|March 16, 2010
Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 2010;57:766-73Tommaso Cai, Lorenzo Giuseppe Luciani, Gianni Malossini
European Urology|June 28, 2020
Re: Jan-Niclas Mumm, Andreas Osterman, Michael Ruzicka, et al. Urinary Frequency as a Possible Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.05.013: Severe Involvement of the Urinary Tract During COVID-19 InfectionLorenzo G Luciani, Fabrizio Gallo, Gianni Malossini
The Journal of Urology|November 25, 2010
Re: Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy: C. Von Bodman, G. Godoy, D. C. Chade, A. Cronin, L. J. Tafe, S. W. Fine, V. Laudone, P. T. Scardino and J. A. Eastham J Urol 2010; 184: 143-148Tommaso Cai, Gabriella Nesi, Gianni Malossini, et al.
The Journal of Antimicrobial Chemotherapy|December 28, 2010
Comment on: A potential role for daptomycin in enterococcal infections: what is the evidence?Tommaso Cai, Sandra Mazzoli, Gianni Malossini, et al.
The Journal of Urology|February 19, 2021
Delaying Cancer Cases in Urology during COVID-19: Review of the Literature. Letter.<i>J Urol</i> 2020; <b>204:</b> 926Tommaso Cai, Orazio Caffo, Gianni Malossini, et al.
Oncology Letters|April 20, 2013
Pelvic and muscular metastasis of a renal cell carcinoma: A case reportCarolina D'Elia, Tommaso Cai, Lorenzo Luciani, et al.
Pageof 8